|
| 26540172 | Next-Generation Sequencing in Oncology in the Era of Precision Medicine. | JAMA Oncol | 2016 |
| 27099173 | A research roadmap for next-generation sequencing informatics. | Sci Transl Med | 2016 |
| 26053648 | FDA oversight of laboratory-developed tests will facilitate adoption of pharmacogenetic testing into routine clinical care. | Journal of Clinical Pharmacology | 2015 |
| 26014594 | The FDA and genetic testing. | New England Journal of Medicine | 2015 |
| 24634466 | Evidence of clinical utility: an unmet need in molecular diagnostics for patients with cancer. | Clin Cancer Res | 2014 |
| 24443746 | Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach. | Mol Cell Proteomics | 2014 |
| 24634468 | FDA perspective on companion diagnostics: an evolving paradigm. | Clinical Cancer Research | 2014 |
| 23692697 | Continuing to strengthen FDA's science approach to emerging technologies. | Nanomedicine | 2013 |
| 24063748 | Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies. | J Proteome Res | 2013 |
| 21826252 | Biospecimen Reporting for Improved Study Quality. | Biopreserv Biobank | 2011 |
| 21433001 | Biospecimen reporting for improved study quality (BRISQ). | Cancer Cytopathol | 2011 |
| 21300740 | The journey to regulation of protein-based multiplex quantitative assays. | Clin Chem | 2011 |
| 21574648 | Biospecimen reporting for improved study quality (BRISQ). | J Proteome Res | 2011 |
| 21885623 | Direct-to-consumer genetic testing: reliable or risky? | Clin Chem | 2011 |
| 20007858 | Protein-based multiplex assays: mock presubmissions to the US Food and Drug Administration. | Clin Chem | 2010 |
| 29776248 | US FDA and personalized medicine: in vitro diagnostic regulatory perspective. | Per Med | 2010 |
| 22833953 | Biomarkers to improve the benefit/risk balance for approved therapeutics: a US FDA perspective on personalized medicine. | Ther Deliv | 2010 |
| 20864915 | Companion diagnostics. | Clinical Advances in Hematology and Oncology | 2010 |
| 21142909 | Development and regulatory strategies for drug and diagnostic co-development. | Pharmacogenomics | 2010 |
| 20007859 | Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA interagency oncology task force on molecular diagnostics. | Clin Chem | 2010 |
| 24980716 | Biomarkers for pharmacogenetic and pharmacogenomic studies: Locking down analytical performance. | Drug Discov Today Technol | 2007 |
| 24980717 | Biomarkers for pharmacogenetic and pharmacogenomic studies: special issues in analytical performance. | Drug Discov Today Technol | 2007 |
| 15681468 | Food and Drug Administration regulation of in vitro diagnostic devices. | Journal of Molecular Diagnostics | 2005 |
| 12723455 | Pharmacogenetics and pharmacogenomics in drug development and regulatory decision making: report of the first FDA-PWG-PhRMA-DruSafe Workshop. | J Clin Pharmacol | 2003 |
| 14595024 | Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. | Proceedings of the National Academy of Sciences of the United States of America | 2003 |
| 11443543 | The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. | Am J Hum Genet | 2001 |
| 11468188 | The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments. | Blood | 2001 |
| 10807793 | The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. | Blood | 2000 |
| 10199409 | Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. | Cell | 1999 |
| 9847080 | Construction of an approximately 700-kb transcript map around the familial Mediterranean fever locus on human chromosome 16p13.3. | Genome Res | 1998 |
| 14646554 | Effects of BCL-2 overexpression on the sensitivity of MCF-7 breast cancer cells to ricin, diphtheria and Pseudomonas toxin and immunotoxins. | Apoptosis : an international journal on programmed cell death | 1997 |
| 9191188 | Recombinant RFB4 single-chain immunotoxin that is cytotoxic towards CD22-positive cells. | Biochemical Society Transactions | 1997 |
| 9292538 | Recombinant RFB4 immunotoxins exhibit potent cytotoxic activity for CD22-bearing cells and tumors. | Blood | 1997 |
| 8889017 | Characterization of RFB4-Pseudomonas exotoxin A immunotoxins targeted to CD22 on B-cell malignancies. | Bioconjugate Chemistry | 1996 |
| 7958417 | Genetic and molecular analysis of hyperplastic discs, a gene whose product is required for regulation of cell proliferation in Drosophila melanogaster imaginal discs and germ cells. | Developmental Biology | 1994 |